Detection of the c-myc gene product in urinary bladder cancer

Jpn J Cancer Res. 1990 Dec;81(12):1198-201. doi: 10.1111/j.1349-7006.1990.tb02677.x.

Abstract

Expression of the c-myc gene product in urinary bladder cancer was investigated by immunohistochemical staining with anti-c-myc monoclonal antibody (mAb) MYC-1. Positive staining was observed in the cytoplasm, but not in the nucleus in tissues fixed with 10% formalin. On the other hand, positive staining was localized in the nucleus in cryopreserved tissues. Of 34 cryopreserved specimens examined, positive staining with MYC-1 mAb was observed in 1 of 12 (8.3%) of grade 1 (G1), 12 of 15 (80%) of G2 and 6 of 7 (86%) of G3. Positive staining with Ki-67 mAb was observed in 2 of 12 (17%) of G1, 12 of 15 (80%) of G2, and 6 of 7 (86%) of G3. These results suggest that tumors with higher nuclear pleomorphism contain more proliferating cells.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Carcinoma, Transitional Cell / chemistry
  • Carcinoma, Transitional Cell / genetics*
  • Carcinoma, Transitional Cell / pathology
  • Cell Nucleus / chemistry
  • Cryopreservation
  • Cytoplasm / chemistry
  • Gene Expression*
  • Humans
  • Immunoenzyme Techniques
  • Paraffin
  • Prognosis
  • Proto-Oncogene Proteins c-myc / analysis*
  • Urinary Bladder Neoplasms / chemistry
  • Urinary Bladder Neoplasms / genetics*
  • Urinary Bladder Neoplasms / pathology

Substances

  • Proto-Oncogene Proteins c-myc
  • Paraffin